Survivin c.-31G>C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis.
gene
bladder cancer
genetic association
genetic polymorphism
meta-analysis
prostate cancer
renal cell cancer
rs9904341
urinary system cancer
urothelial cancer
Journal
Personalized medicine
ISSN: 1744-828X
Titre abrégé: Per Med
Pays: England
ID NLM: 101238549
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
pubmed:
23
11
2018
medline:
3
1
2019
entrez:
23
11
2018
Statut:
ppublish
Résumé
To investigate the possible association between survivin c.-31G>C (rs9904341) gene polymorphism and urinary system cancers by a meta-analysis approach. Standard electronic literature databases were searched to find eligible studies. The odds ratios (ORs) with 95% CIs were estimated to find the associations possibility. Overall meta-analysis revealed significant associations between c.-31G>C transversion and risk of urinary tract cancers in dominant (OR: 1.34; 95% CI: 1.02-1.75; p = 0.035), recessive (OR: 1.52; 95% CI: 1.33-1.74; p < 0.001) and homozygote codominant (OR: 1.90; 95% Cl: 1.37-2.62; p < 0.001) genetic models. The c.-31G>C transversion might be a risk factor for urinary system cancers. However, more articles with different ethnicities will help to obtain a more accurate conclusion.
Identifiants
pubmed: 30465472
doi: 10.2217/pme-2018-0053
doi:
Substances chimiques
BIRC5 protein, human
0
Survivin
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM